(S)-3-(3-((7-Ethynyl-9H-pyrimido[4,5-b]indol-4-yl)amino)piperidin-1-yl)propanenitrile

URN to cite this document:: urn:nbn:de:bvb:355-epub-529456
DOI to cite this document:: 10.5283/epub.52945

Andreev, Stanislav

; Plank, Nicole ; Schollmeyer, Dieter ; Koch, Pierre

	PDF - Supplemental Material Supplementary Materials (1MB)
	License: Creative Commons Attribution 4.0 PDF - Published Version (4MB)

Date of publication of this fulltext: 29 Sep 2022 10:23

Alternative links to fulltext:DOI Publisher

Details

Preview: Supplementary Materials

Preview

Export bibliographical data

Abstract

The title compound (S)-3-(3-((7-ethynyl-9H-pyrimido[4,5-b]indol-4-yl)amino)piperidin-1-yl)propanenitrile (2) was synthesized in five steps, starting from 4-chloro-7-iodo-9H-pyrimido[4,5-b]indole (3), and was characterized by 1H-NMR, 13C-NMR, MS and HPLC. Moreover, its structure was confirmed by single crystal X-ray diffraction. Pyrimido[4,5-b]indole 2 demonstrated an IC50 value of 2.24 µM in a NanoBRETTM TE intracellular glycogen synthase kinase-3β assay.

Owner only: item control page

Download Statistics